Investor Presentaiton

2021 Guidance Re-Affirmed $ in Millions 2020 2021 % Change Net Sales $318.8 >$430 +35% Adjusted EBITDA $46.9 >$61 +30% ⚫ ERP Conversion: Tentatively targeted for 10/1/21 ⚫ COVID Addback: Anticipating $2.0 million in COVID-related costs until broadscale vaccination has occurred 55

View entire presentation